Brief: Akari Therapeutics PLC Files Prospectus Relates To Resale, By Selling Shareholders Of Up To An Aggregate Of 2.78 Bln Ordinary Shares
12/10/2022 22:29
Oct 12 (Reuters) - Akari Therapeutics PLC AKTX.O :
* AKARI THERAPEUTICS PLC FILES PROSPECTUS RELATES TO RESALE,
BY
SELLING SHAREHOLDERS OF UP TO AN AGGREGATE OF 2.78 BILLION
ORDINARY SHARES
Further company coverage: AKTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akari Therapeutics
See all newsBrief: Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity In Urothelial Cancer Preclinical Models
UK's Akari Therapeutics Q2 net loss widens on higher R&D for AKTX-101
Akari Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Akari Therapeutics PLC expected to post a loss of $1.40 a share - Earnings Preview
Brief: Akari Therapeutics Enters Strategic Research Collaboration With Whitehawk Therapeutics